A 42-year-old man received a cardiac transplantation in October 1995 for dilated cardiomyopathy. He had no history of hyperlipidemia or coronary artery disease. The heart donor was a 41-year-old woman with a history of hypertension. The first intravascular ultrasound (IVUS) study was obtained 14 days after cardiac transplantation, and the last follow-up examination was performed 5 years later. Figures 1 and 2 show a hypoechoic atheroma in the proximal left anterior descending artery that was transmitted from the donor. At this site, serial IVUS imaging demonstrates apparent spontaneous regression of the donor atheroma (Figures 1  and 2) . The presence of prominent perivascular landmarks confirms the identical location of IVUS images from both time points. Of note, the regression in atheroma volume is accompanied by new calcification, a process that is thought to represent plaque stabilization. These changes show a dramatic regression in a transmitted donor atheroma after cardiac transplantation and suggest the potential for antiatherosclerotic therapy to regress atherosclerosis in the natural course of native coronary artery disease.
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